Report Library
All ReportsDatapack – Pharmaprojects Pharma R&D Annual Review 2016
December 02, 2016
Stay informed on industry R&D trends and perform your own in-depth analysis. This datapack presents the supporting data from our seminal
white paper, Pharmaprojects Pharma R&D Annual Review 2016. Over the past 25 years, the pharma R&D sector has seen many twists
and turns. Included with your purchase, our white paper looks at developments in a year that saw some new players make the big time, while
others hit skid row after one too many negative (clinical) reviews. Sourced from Pharmaprojects, the industry's most trusted clinical drug
development database, the information included in this datapack covers multiple views of the R&D pipeline by company, development phase,
therapy area, and more, allowing you to perform your own analysis and dive deeper into the underlying data.
Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |